Moderate progress for ovarian cancer in the last 20 years: prolongation of survival, but no improvement in the cure rate
- 1 December 2002
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 38 (18), 2435-2445
- https://doi.org/10.1016/s0959-8049(02)00495-1
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Ovarian cancer: Age contrasts in incidence, histology, disease stage at diagnosis, and mortalityCancer, 2010
- Ovarian cancer: Survival and treatment differences by ageCancer, 2010
- Time trends in ovarian cancer mortality in Europe (1955–1993)European Journal Of Cancer, 2000
- Randomized Intergroup Trial of Cisplatin-Paclitaxel Versus Cisplatin-Cyclophosphamide in Women With Advanced Epithelial Ovarian Cancer: Three-Year ResultsJNCI Journal of the National Cancer Institute, 2000
- Cyclophosphamide and Cisplatin Compared with Paclitaxel and Cisplatin in Patients with Stage III and Stage IV Ovarian CancerNew England Journal of Medicine, 1996
- The influence of cytoreductive surgery on recurrence-free interval and survival in small-volume Stage III epithelial ovarian cancer: A gynecologic oncology group studyGynecologic Oncology, 1992
- Descriptive epidemiology of ovarian cancer in EuropeGynecologic Oncology, 1992
- Chemotherapy in advanced ovarian cancer: an overview of randomised clinical trials. Advanced Ovarian Cancer Trialists Group.BMJ, 1991
- Improved prognosis of ovarian cancer in The Netherlands during the period 1975–1985: A registry-based studyGynecologic Oncology, 1991
- Tumor reduction surgery and long-term survival in advanced ovarian cancer: A DACOVA studyGynecologic Oncology, 1990